Breaking Down Cofinimmo SA Financial Health: Key Insights for Investors

If you're tracking European real-estate names, Cofinimmo SA (COFB.BR) demands attention: H1 2025 saw gross rental income of €177 million (nearly 3% like‑for‑like growth) and EPRA earnings of €122 million (up 2.4% y/y) as the group pushes a strategic tilt that places 77% of its €6.0 billion portfolio in healthcare assets, supported by a fleet-wide occupancy rate of 98.6% and an average residual lease length of 13 years; profitability signals include Q1 operating margins of 65%, EBIT of €279.8 million with an interest coverage ratio of 4.9, EPS of €3.19 for H1 2025 and a market cap of €2.9 billion with shares trading at a 32% discount to IFRS NAV, while capital structure and risk metrics show a debt-to-assets ratio of 44.4%, debt-to-equity of 73.8%, an average cost of debt of 1.4%, a Debt/FCF of 9.30 and an Altman‑Z score of 0.81-add to that an intrinsic valuation estimate of €77.88 implying an ~11% upside from the €70.15 share price and valuation multiples (P/E 48.88; EV/EBITDA 116.02) that temper the picture, with liquidity headroom from €27.1 million cash and €866 million committed credit lines and a BBB/Stable/A‑2 S&P rating confirmed on 25 March 2025 - read on to unpack what these figures mean for investors.

Cofinimmo SA (COFB.BR) - Revenue Analysis

• Gross rental income (H1 2025): €177 million
• Like-for-like rental growth (H1 2025): ~3.0% overall
• EPRA Earnings (Net result from core activities, H1 2025): €122 million (+2.4% YoY)
• Portfolio size: €6.0 billion
• Healthcare allocation: 77% of portfolio value
• Average residual lease length: 13 years
• Occupancy rate: 98.6%

• High occupancy (98.6%) combined with a long average residual lease length (13 years) underpins predictable cash flows and lowers short-term re-letting risk.
• Healthcare weighting (77% of €6.0bn) increases exposure to a defensive, demographic-driven sector, which supports rental resilience.
• EPRA Earnings growth (+2.4% YoY) indicates modest margin expansion or effective cost and portfolio management alongside rent growth.

Cofinimmo SA (COFB.BR) - Profitability Metrics

• Operating profit margin (Q1 2025): 65% - indicates tight cost control and high operating leverage on rental and property management income.
• Net profit (Q1 2025): €25.0 million, up 25% from €20.0 million in Q1 2024.
• EBIT (latest period): €279.8 million, producing an interest coverage ratio of 4.9x.
• ROIC: slightly above WACC - signalling marginal value creation on invested capital.
• EPS (H1 2025): €3.19, marginally below the prior-year H1 figure.
• Market capitalization (as of 23 Apr 2025): €2.9 billion; shares trading at a 32% discount to IFRS NAV.

• Interest coverage (4.9x) provides a reasonable buffer for servicing debt but warrants monitoring if interest rates or leverage shift.
• The mix of high operating margin and near-WACC ROIC suggests stable cash generation without large excess returns - an expected profile for a diversified listed real estate investment company.
• Valuation gap (32% discount to IFRS NAV) is a key input for total-return and dividend-yield assessments.

Cofinimmo SA (COFB.BR) - Debt vs. Equity Structure

• Leverage profile: 44.4% debt-to-assets and 73.8% debt-to-equity reflect a real-estate capital structure that uses meaningful debt to enhance equity returns while keeping asset coverage.
• Cost environment: 1.4% average cost of debt is a structural advantage versus market rates - lowers financing pressure and supports NOI retention.
• Interest buffer: 4.9x interest coverage is adequate for current operations but not overly conservative; earnings volatility could compress this quickly.
• Solvency warning: Altman-Z at 0.81 is a red flag: it signals heightened insolvency risk under stress scenarios despite favorable debt pricing.
• Liquidity perspective: Debt-to-FCF at 9.30x implies a multi-year horizon to extinguish liabilities from operating cash - limits flexibility for aggressive deleveraging without asset sales or new capital.

• Investor implications:
  • Yield-seeking investors benefit from leverage-amplified returns if rental income and occupancy remain stable.
  • Risk-sensitive investors should monitor refinancing maturities, covenant levels and asset-liability duration mismatches.
  • Watch for debt amortization schedule and potential for asset disposals to improve Debt/FCF and Altman-Z ratios.

For context on strategy and corporate priorities that interact with this capital structure, see: Mission Statement, Vision, & Core Values (2026) of Cofinimmo SA.

Cofinimmo SA (COFB.BR) Liquidity and Solvency

Cofinimmo's balance-sheet snapshot and funding profile indicate a broadly solid liquidity and solvency position supported by conservative leverage, sizable committed credit lines and a low average cost of debt.

• Cash & short-term investments: €27.1 million.
• Total assets: €6.4 billion; total liabilities: €2.9 billion; total equity: €3.5 billion.
• Committed credit line headroom available: €866 million for new opportunities.
• Average cost of debt: 1.4% (low financing cost helps interest cover and cash flow resilience).
• S&P rating: BBB/Stable/A-2 (confirmed 25 March 2025).

• Strengths: sizeable equity base (€3.5B), conservative overall leverage (debt-to-assets ~45%), strong committed liquidity (€866M), low average funding cost (1.4%), investment-grade S&P rating.
• Watchpoints: relatively modest on-balance immediate cash (€27.1M) versus short-term obligations - mitigated by committed lines and capital markets access.
• Implication for investors: the capital structure supports growth and opportunistic deployments while preserving credit metrics; further details on maturities and covenant profile should be checked in the investor report linked below.

Exploring Cofinimmo SA Investor Profile: Who's Buying and Why?

Cofinimmo SA (COFB.BR) Valuation Analysis

Cofinimmo SA (COFB.BR) presents a mixed valuation picture: an intrinsic value above the current share price, substantial market capitalization, but high conventional valuation multiples versus peers. Key inputs and implications follow.

• Estimated intrinsic value: €77.88 per share - implies ~11% upside from current market price of €70.15.
• Market capitalization: €2.9 billion.
• IFRS NAV discount: shares trade at a ~32% discount to IFRS NAV.
• Price-to-Earnings (P/E) ratio: 48.88 - notably premium relative to typical REIT/healthcare real estate peers.
• Enterprise Value-to-EBITDA (EV/EBITDA): 116.02 - an elevated multiple reflecting low reported EBITDA or high enterprise value.
• Valuation drivers: intrinsic value higher than market price and a strong European healthcare real estate portfolio support upside potential.

Valuation interpretation and drivers:

• The intrinsic value of €77.88 suggests an investor-visible margin of safety relative to the current price, supporting a buy-case if operational fundamentals hold.
• The 32% discount to IFRS NAV signals market skepticism or structural illiquidity; this discount can coexist with a premium P/E and EV/EBITDA when earnings are temporarily depressed or adjusted for revaluation gains.
• High P/E (48.88) and EV/EBITDA (116.02) indicate that conventional earnings-based multiples portray Cofinimmo as richly valued; these should be interpreted alongside NAV-based and asset-driven valuations given the REIT/real-estate nature of the business.
• Balance between NAV discount and intrinsic upside: the NAV discount suggests potential for capital appreciation if asset valuations re-rate, while the intrinsic model points to an 11% share-price upside today.
• Portfolio quality is a key qualitative support: a diversified portfolio of healthcare real estate across Europe underpins long-term cash flow visibility and lends credibility to intrinsic valuations.

For governance, mission alignment and broader corporate positioning, see: Mission Statement, Vision, & Core Values (2026) of Cofinimmo SA.

Cofinimmo SA (COFB.BR) Risk Factors

Cofinimmo SA (COFB.BR) faces a set of concrete financial and operational risks that investors should monitor closely. The key quantifiable metrics and situational risks below frame the company's current vulnerability profile and potential stress points.

• Regulatory & Transactional Risk: The potential combination with Aedifica is contingent on regulatory approvals - investors should expect possible delays, conditions, or even prohibition that could change pro forma leverage, synergies, and integration timelines.
• Leverage & Liquidity Risk: A 73.8% debt-to-equity ratio combined with Debt/FCF of 9.30 implies limited margin for adverse cash-flow shocks; refinancing or higher rates would materially raise interest costs and stress liquidity.
• Distress Indicator: An Altman-Z score of 0.81 places Cofinimmo in a zone historically associated with higher default probability, warranting close monitoring of covenant headroom, cash reserves, and near-term maturities.
• Valuation Risk: Elevated P/E (48.88) and EV/EBITDA (116.02) multiples suggest the market prices in strong future growth or low risk - any disappointment in earnings, occupancy, or funding costs could lead to sharp valuation declines.
• Sector & Regulatory Exposure: Concentration in healthcare properties exposes income stability to policy changes (reimbursement, facility licensing), demographic shifts, and operational reforms in care delivery.

Operational and covenant monitoring items for investors:

• Debt maturity schedule, refinancing needs, and interest coverage ratios.
• Free cash flow trends vs. projections and sensitivity to occupancy or rent renegotiations.
• Status and conditions of the Aedifica transaction, including regulatory filings and expected timelines.
• Tenant mix and lease duration in healthcare assets; exposure to public-payor contracts or single large tenants.
• Market sentiment and comparables that could affect implied multiples and access to capital.

Quick reference - snapshot table of the primary quantitative risk metrics:

For additional corporate background and context on strategy, ownership and how Cofinimmo generates returns, see: Cofinimmo SA: History, Ownership, Mission, How It Works & Makes Money

Cofinimmo SA (COFB.BR) - Growth Opportunities

• Strategic specialization: deliberate tilt to healthcare assets (nursing homes, assisted living, medical office buildings, Belgian psychiatric infrastructure) to capture resilient rental demand and higher yield spreads versus generic office assets.
• Geographic diversification: portfolio presence in nine European countries reduces single-market risk while accessing heterogeneous demand drivers and funding environments.
• Asset rotation: active divestments of non-core or mature assets and targeted acquisitions in healthcare to optimize yield and improve portfolio quality over time.
• Sustainability and ESG: ongoing ESG initiatives (energy efficiency upgrades, green building certifications, tenant engagement programs) that enhance tenant retention and appeal to the growing universe of ESG-focused investors.
• Financial capacity: conservative leverage profile and low funding costs that enable further accretive investments.

• Portfolio optimization mechanics: selling lower-yield or non-strategic assets to recycle capital into higher-growth healthcare assets-capturing yield compression upside while improving asset quality.
• Balance sheet strength: with a sub-45% leverage ratio and 1.4% average cost of debt, Cofinimmo is well-positioned to deploy capital into accretive acquisitions without materially increasing funding risk.
• Operational tailwinds: 98.6% occupancy and a 13-year average lease tenor reduce short-term re-letting risk and support stable dividend coverage.